Aurentz Vincent

Chief Business Officer, EPIRUS Biopharmaceuticals, Inc.

Companies

Inhibikase Therapeutics, Inc.Board member Feb 25, 2025 to now¹
Longboard Pharmaceuticals, Inc.Board member Mar 11, 2021 to Dec 2, 2024²
Arena PharmaceuticalsExecutive VP and CBO Aug 15, 2016 to Mar 11, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibikase Therapeutics, Inc. IKT510,596 shares⁴$804.2K at $1.57Feb 21, 2026
Arena Pharmaceuticals ARNA0 shares⁵Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 21, 2026Returned to company 255,299 shares of Inhibikase Therapeutics, Inc.⁴
Mar 11, 2022Other 21,462 shares of Arena Pharmaceuticals⁵
Mar 11, 2022Other 6,660 shares of Arena Pharmaceuticals⁵
Mar 11, 2022Other 27,842 shares of Arena Pharmaceuticals⁵
Jan 3, 2022Granted 21,462 shares of Arena Pharmaceuticals⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibikase Therapeutics, Inc., Board member
2
SEC EDGARLongboard Pharmaceuticals, Inc., Board member
3
SEC EDGARArena Pharmaceuticals, Executive VP and CBO
4
SEC EDGARInhibikase Therapeutics, Inc. shares after the filing of Feb 21, 2026
5
SEC EDGARArena Pharmaceuticals shares after the filing of Mar 11, 2022
6
SEC EDGARForm 4 filed Jan 5, 2022